These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 28511795

  • 1. miR-142-5p regulates tumor cell PD-L1 expression and enhances anti-tumor immunity.
    Jia L, Xi Q, Wang H, Zhang Z, Liu H, Cheng Y, Guo X, Zhang J, Zhang Q, Zhang L, Xue Z, Li Y, Da Y, Zhao P, Zhang R.
    Biochem Biophys Res Commun; 2017 Jun 24; 488(2):425-431. PubMed ID: 28511795
    [Abstract] [Full Text] [Related]

  • 2. miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer.
    Wang C, Li X, Zhang L, Chen Y, Dong R, Zhang J, Zhao J, Guo X, Yang G, Li Y, Gu C, Xi Q, Zhang R.
    Int Immunopharmacol; 2021 Aug 24; 97():107822. PubMed ID: 34098485
    [Abstract] [Full Text] [Related]

  • 3. The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer.
    Zhao L, Yu H, Yi S, Peng X, Su P, Xiao Z, Liu R, Tang A, Li X, Liu F, Shen S.
    Oncotarget; 2016 Jul 19; 7(29):45370-45384. PubMed ID: 27248318
    [Abstract] [Full Text] [Related]

  • 4. Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p.
    Zhou WY, Zhang MM, Liu C, Kang Y, Wang JO, Yang XH.
    J Cell Physiol; 2019 Dec 19; 234(12):23176-23189. PubMed ID: 31206665
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. microRNA-20b-5p overexpression combing Pembrolizumab potentiates cancer cells to radiation therapy via repressing programmed death-ligand 1.
    Jiang K, Zou H.
    Bioengineered; 2022 Jan 19; 13(1):917-929. PubMed ID: 34968160
    [Abstract] [Full Text] [Related]

  • 7. miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer.
    Miliotis C, Slack FJ.
    Cancer Lett; 2021 Oct 10; 518():115-126. PubMed ID: 34098061
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MiR-195/-16 Family Enhances Radiotherapy via T Cell Activation in the Tumor Microenvironment by Blocking the PD-L1 Immune Checkpoint.
    Tao Z, Xu S, Ruan H, Wang T, Song W, Qian L, Chen K.
    Cell Physiol Biochem; 2018 Oct 10; 48(2):801-814. PubMed ID: 30032144
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The EGFR-P38 MAPK axis up-regulates PD-L1 through miR-675-5p and down-regulates HLA-ABC via hexokinase-2 in hepatocellular carcinoma cells.
    Liu Z, Ning F, Cai Y, Sheng H, Zheng R, Yin X, Lu Z, Su L, Chen X, Zeng C, Wang H, Liu L.
    Cancer Commun (Lond); 2021 Jan 10; 41(1):62-78. PubMed ID: 34236149
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma.
    Chen XY, Zhang J, Hou LD, Zhang R, Chen W, Fan HN, Huang YX, Liu H, Zhu JS.
    Int J Immunopathol Pharmacol; 2018 Jan 10; 32():2058738418790318. PubMed ID: 30045644
    [Abstract] [Full Text] [Related]

  • 19. Bone marrow mesenchymal stromal cells attenuate liver allograft rejection may via upregulation PD-L1 expression through downregulation of miR-17-5p.
    Chen Q, Zhou R, Zhang Y, Zhu S, Xiao C, Gong J, Li K, Tang H, Sun C, Zhang J.
    Transpl Immunol; 2018 Dec 10; 51():21-29. PubMed ID: 30092337
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.